Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

¥42.12As of Sun 8 Nov 2026, 12:00 UTC
SSE:600329Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR 12.91%
Div yield 11.11%
ROE 11.52%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.36
PE TTM 36.24
TSR TTM 4.57%
Mkt cap ¥27.47B
ROIC 25.38%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥44
4.34%
(61.78%)
Hold 5|1|2|3|12
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.54
0.60
0.57
0.59
19.44%
22.27%
14.13%
14.75%
Revenue¥B
1.185
1.248
1.247
1.312
(0.76%)
2.11%
(0.64%)
7.71%
Peers (US$4.118B)
Cap (US$)
PE
4.020B
19.40x
3.934B
28.04x
3.974B
30.04x
Capital
TTM
5Y
10Y
Leveragex
0.980
0.128
0.096
EBIT/Intx
1.639
2.317
2.215
Own earn%
(51.54)
(3.28)
(3.77)
Sh yield%
24.38
50.90
50.13
Owners
Insiders/Inst%
12.83
74.36
Short interest%
3.90
SBC / revenue%
5.90
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
8–16
$1 testx
—
Incr. ROIC%
4